SMS Pharmaceuticals Limited reported a 16.1% year-on-year increase in standalone net profit for the first quarter of FY27, supported by higher revenues and improved operational performance.

For the quarter ended June 30, 2026, the Hyderabad-based active pharmaceutical ingredient (API) manufacturer reported standalone revenue from operations of Rs. 206.96 crore, up 5.6% from Rs. 196.05 crore in the corresponding quarter of the previous fiscal. However, revenue declined sequentially from Rs. 237.95 crore reported in the March 2026 quarter.

Including other income, the company's total standalone income stood at Rs. 208.71 crore, compared with Rs. 196.64 crore in the year-ago period.

Standalone profit before tax (PBT) increased 17.9% year-on-year to Rs. 28.14 crore, while net profit after tax (PAT) rose to Rs. 21.13 crore from Rs. 18.21 crore in Q1 FY26.

The company reported basic and diluted earnings per share (EPS) of Rs. 2.26 for the quarter.

Total standalone expenses stood at Rs. 180.57 crore, lower than the preceding quarter. Raw material consumption remained the largest cost component at Rs. 135.72 crore, while employee benefit expenses were Rs. 23.30 crore. Finance costs and depreciation stood at Rs. 5.50 crore and Rs. 9.99 crore, respectively.

On a consolidated basis, SMS Pharmaceuticals reported revenue from operations of Rs. 206.96 crore and total income of Rs. 208.71 crore during the quarter.

Consolidated profit before tax rose to Rs. 27.21 crore, compared with Rs. 24.37 crore in the corresponding quarter last year. After accounting for taxes and a Rs. 0.71 crore share of profit from associates, consolidated net profit attributable to equity shareholders stood at Rs. 20.91 crore, a 2% increase over Rs. 20.49 crore reported in Q1 FY26.

Consolidated earnings per share for the quarter were Rs. 2.23.

The company's paid-up equity share capital remained unchanged at Rs. 9.37 crore, while standalone other equity stood at Rs. 795.42 crore.

Shares of SMS Pharmaceuticals were last trading at Rs. 374.20 on the BSE, marginally higher than the previous close of Rs. 373.75.